Keywords
Syndrome Metabolic
Obesity
High blood pressure
Dyslipidemia
How to Cite
Abstract
Background. Periodontal disease (PD) is a chronic inflammatory condition that destroys dental support tissues, leading to tooth loss. It is associated with Metabolic Syndrome (MS), which includes obesity, dyslipidemia, and hypertension. Combined with PD parameters, these factors contribute to an increased risk of cardiovascular problems. Aim. To evaluate the relationship between MS components and PD parameters in patients with type 2 diabetes (T2D). Methods A descriptive and correlational study was conducted. Clinical records of 39 patients with PD and T2D from the Dr. Rafael Lucio High Specialty Center in Xalapa, Veracruz, were analyzed. Results Significant correlations were identified between probing bleeding levels and glucose levels (r=0.3452, p=0.0214), mean arterial pressure and clinical attachment levels (r=0.3322, p=0.0268), and probing bleeding with mean arterial pressure (r=0.5346, p=0.0268). Conclusion: A direct relationship was observed between the components of MS and the clinical parameters of periodontal disease.
References
Fahed G, Aoun L, Bou Zerdan M, Allam S, Bou Zerdan M, Bouferraa Y, Assi HI. (2021). Metabolic Syndrome: Updates on Pathophysiology and Management in 2021. Int J Mol Sci, 23(2): 786. Doi 10.3390/ijms23020786.
Hlushchenko, T.,Batig, M., Borysenko, A., Tokar, O., Batih, I., Vynogradova, O., Boychuk-Tovsta, O.(2020) Prevalence and intensity of periodontal diseases in individuals with metabolic syndrome. J. Med Life,13(3): 289-292. 10.25122/jml-2020-0073.
Jepsen, S., Suvan, J., Deschner,J. (2020). The association of periodontal diseases with metabolic syndrome and obesity. Periodontol 2000,83(1):125-153.Doi 10.1111/prd.12326.
Katsimardou, A., Imprilaos, K., Stavropolos, K., Sachinidis, A., Doumas, M., Athyros, V.(2020) Hypertension in metabolic syndrome: Novel Insights.Curr Hypertens Rev,16(1):12-18. Doi 10.2174/1573402115666190415161813.
Mikami,R., Mizutani, K., Matsuyama, Y., Matsuura, T., Kido, D., Takeda, K., Takemura, S., Nakagawa, K., Mukaiyama, Y., Suda, T., Yasuda, T., Ohta, S., Takaya, N., Fujkiwara, T., Izumi, Y., Iwata, T(2021). Association between periodontal inflammations and serum lipid profile in healthy population: A cross-sectional study. J Periodont Res, 56(6):1-9.Doi 10.1111/jre.12917.
Nesse, W., Abbas, F., Van der Ploeg, I., Spijkervet, F., Dijkstra, P., Vissink, A.(2008) Periodontal Inflamed area: quantifying inflammatory burden. J Clin Periodontol,35(8): 668-673. Doi 10.1111/j.1600-051X.2008.01249.x
Preshaw, P., Taylor, J., Jaedicke, K., De Jager, M., Bikker, J, Selten W, Bissett S, Whall K, Van de Merwe R, Areibi A, Jitprasertwong P, Al-Shahwani R., Weaver, J., Taylor, R., Wassall, R.(2020) Treatment of periodontitis reduces systemic inflammation in type 2 diabetes. J. Clin Periodontiol, 47(6):737-746. Doi 10.1111/jcpe.13274.
Saklayen,MG.(2018) The Global Epidemic of the Metabolic Syndrome. Curr. Hypertens Rep,20(2):1-8. Doi 10.1007/s11906-018-0812-z.
Sherling, DH., Perumareddi, P., Hennekens, H. (2017) Metabolic Syndrome: Clinical and Policy Imnplications of the new silent killer. J. Cardiovasc. Pharmacol Ther, 22(4), 365-367. Doi 10.1177/1074248416686187.
Srivastava,M., Srivastava, R., Kumar Verma P, Gautam A.(2019). Metabolic syndrome and periodontal disease: An Overview for physicians. J Family Med Prim Care,8(11):3492-3495. Doi 10.4103/jfmpc.jfmpc_866_19.
Pietripaoliu D, Del pinto R, Ferri C, Wright JT,Giannoni M, ortu E, Monaco A.(2018) Poor oral healts and blood pressure control among US Hypertensive Adults.Hypertension AHA,72(6):1365-1373. Doi: 10.1161/HYPERTENSIONAHA.118.11528/
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright (c) 2025 José Carlos Alarcón-Moreno , María Gabriela Nachón-García, Mónica Flores-Muñoz , Francisco Javier Nachón-García , Miguel Eric García-Rivera , Víctor Hugo Muñoz-Muñoz